BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals Reports 100% Protection From H1N1 Challenge When Using BioVant(TM) Adjuvanted Vaccine
Published in Vaccine Weekly, September 2nd, 2009
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced's presentation of H1N1 vaccine results at the Immunotherapeutics & Vaccine Summit in Providence, RI. BioSante's vaccine adjuvant, BioVant™, increased the protective effect of vaccines for multiple flu strains, including a potential new vaccine against H1N1 (swine flu), which resulted in 100 percent protection from symptoms of illness, including weight loss, and death in animal studies.
The BioSante presentation, "BioVant Calcium Phosphate (CaP) Nanoparticles: An Effective & Safe Adjuvant for Influenza Vaccines including H1N1 and H5N1," showed that BioVant-adjuvant effectively enhanced the natural immune...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-09-02)
More Articles from Vaccine Weekly
- JAMA and Archives Journals
Study examines adverse events associated with human papillomavirus vaccine - Allergies
Research findings from University of California, Medical Department update understanding of allergies - Apoptosis
Findings from Kyushu University in apoptosis reported - Burn Care
Studies from Adnan Menderes University, Medical Department provide new data on burn care - Cancer
Research from National Cheng-Kung University, Medical Department has provided new information about cancer - Hepatitis A Virus
New hepatitis A virus study findings have been reported by scientists at Dongguk University - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
